| 1. |
- Angelin, Anna, et al.
(författare)
-
Etnifiering av social utsatthet
- 2022. - 1
-
Ingår i: Socialt arbete i förändring : utmaningar och villkor inom utbildning, forskning och praktik - utmaningar och villkor inom utbildning, forskning och praktik. - Lund : Socialhögskolan, Lunds universitet. - 9789178955459 - 9789178955466 ; , s. 429-442
-
Bokkapitel (populärvet., debatt m.m.)
|
|
| 2. |
- Singh, Kailash, et al.
(författare)
-
Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells
- 2015
-
Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 5
-
Tidskriftsartikel (refereegranskat)abstract
- The anti-inflammatory cytokine IL-35 is produced by regulatory T (Treg) cells to suppress autoimmune and inflammatory responses. The role of IL-35 in type 1 diabetes (T1D) remains to be answered. To elucidate this, we investigated the kinetics of Treg cell response in the multiple low dose streptozotocin induced (MLDSTZ) T1D model and measured the levels of IL-35 in human T1D patients. We found that Treg cells were increased in MLDSTZ mice. However, the Treg cells showed a decreased production of anti-inflammatory (IL-10, IL-35, TGF-beta) and increased pro-inflammatory (IFN-gamma, IL-2, IL-17) cytokines, indicating a phenotypic shift of Treg cells under T1D condition. IL-35 administration effectively both prevented development of, and counteracted established MLDSTZ T1D, seemingly by induction of Eos expression and IL-35 production in Treg cells, thus reversing the phenotypic shift of the Treg cells. IL-35 administration reversed established hyperglycemia in NOD mouse model of T1D. Moreover, circulating IL-35 levels were decreased in human T1D patients compared to healthy controls. These findings suggest that insufficient IL-35 levels play a pivotal role in the development of T1D and that treatment with IL-35 should be investigated in treatment of T1D and other autoimmune diseases.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Bodén, Roger, et al.
(författare)
-
On-chip liquid storage and dispensing for lab-on-a-chip applications
- 2008
-
Ingår i: Journal of Micromechanics and Microengineering. - : IOP Publishing. - 0960-1317 .- 1361-6439. ; 18:7, s. 075036-
-
Tidskriftsartikel (refereegranskat)abstract
- This work presents novel components for on-chip storage and dispensing inside a lab-on-a-chip (LOC) for applications in immunoassay point-of-care testing (POCT), where incubation and washing steps are essential. It involves easy-to-use on-chip solutions for the sequential thermo-hydraulic actuation of liquids. The novel concept of combining the use of a rubber plug, both as a non-return valve cap and as a liquid injection interface of a sealed reservoir, allows simple filling of a sterilized cavity, as well as the storage and dispensing of reagent and washing buffer liquids. Segmenting the flow with air spacers enables effective rinsing and the use of small volumes of on-chip stored liquids. The chip uses low-resistance resistors as heaters in the paraffin actuator, providing the low-voltage actuation that is preferred for handheld battery driven instruments.
|
|
| 8. |
|
|
| 9. |
- Dahlin, Andreas P, et al.
(författare)
-
Multiplexed quantification of proteins adsorbed to surface-modified and non-modified microdialysis membranes
- 2012
-
Ingår i: Analytical and Bioanalytical Chemistry. - : Springer Science and Business Media LLC. - 1618-2642 .- 1618-2650. ; 402:6, s. 2057-2067
-
Tidskriftsartikel (refereegranskat)abstract
- A simple and straightforward method for discovery and quantification of proteins adsorbed onto delicate and sensitive membrane surfaces is presented. The adsorbed proteins were enzymatically cleaved while still adsorbed onto the membranes using an on-surface enzymatic digestion (oSED). This was followed by isobaric tagging, nanoliquid chromatography, and tandem mass spectrometry. Protein adsorption on tri-block copolymer Poloxamer 407 surface-modified microdialysis (MD) membranes were compared with protein adsorption on unmodified MD membranes. Ventricular cerebrospinal fluid (vCSF) kept at 37 °C was used as sample matrix. In total, 19 proteins were quantified in two biological replicates. The surface-modified membranes adsorbed 33% less proteins than control membranes and the most abundant proteins were subunits of hemoglobin and clusterin. The adsorption of clusterin on the modified membranes was on average 36% compared to control membranes. The most common protein in vCSF, Albumin, was not identified adsorbed to the surface at all. It was also experimentally verified that oSED, in conjunction with tandem mass spectrometry can be used to quantify femtomole amounts of proteins adsorbed on limited and delicate surfaces, such as MD membranes. The method has great potential and can be used to study much more complex protein adsorption systems than previously reported.
|
|
| 10. |
|
|
| 11. |
- Eggers, Kai M., 1962-, et al.
(författare)
-
Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries
- 2021
-
Ingår i: Clinical Cardiology. - : John Wiley & Sons. - 0160-9289 .- 1932-8737. ; 44:7, s. 1019-1027
-
Tidskriftsartikel (refereegranskat)abstract
- Background Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition. Recent studies suggest that MINOCA patients may have a proinflammatory disposition. The role of inflammation in MINOCA may thus be distinct to myocardial infarction with significant coronary artery disease (MI-CAD). Hypothesis We hypothesized that inflammation reflected by C-reactive protein (CRP) levels might carry unique clinical information in MINOCA. Methods This retrospective registry-based cohort study (SWEDEHEART) included 9916 patients with MINOCA and 97 970 MI-CAD patients, used for comparisons. Multivariable-adjusted regressions were applied to investigate the associations of CRP levels with clinical variables, all-cause mortality and major cardiovascular events (MACE) during a median follow-up of up to 5.3 years. Results Median admission CRP levels in patients with MINOCA and MI-CAD were 5.0 (interquartile range 2.0-9.0) mg/dl and 5.0 (interquartile range 2.1-10.0 mg/dl), respectively. CRP levels in MINOCA exhibited independent associations with various cardiovascular risk factors, comorbidities and estimates of myocardial damage. The association of CRP with peripheral artery disease tended to be stronger compared to MI-CAD. The associations with female sex, renal dysfunction and myocardial damage were stronger in MI-CAD. CRP independently predicted all-cause mortality in MINOCA (hazard ratio 1.22 [95% confidence interval 1.17-1.26]), similar to MI-CAD (p interaction = 0.904). CRP also predicted MACE (hazard ratio 1.08 [95% confidence interval 1.04-1.12]) but this association was weaker compared to MI-CAD (p interaction<.001). Conclusions We found no evidence indicating the presence of a specific inflammatory pattern in acute MINOCA compared to MI-CAD. However, CRP levels were independently, albeit moderately associated with adverse outcome.
|
|
| 12. |
|
|
| 13. |
- Eggers, Kai M., 1962-, et al.
(författare)
-
Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries
- 2019
-
Ingår i: Journal of Internal Medicine. - : Blackwell Publishing. - 0954-6820 .- 1365-2796. ; 285:4, s. 419-428
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) is receiving increasing interest as a prognostically adverse entity distinct from myocardial infarction with significant coronary artery disease (MI-CAD). However, data are still limited regarding long-term cardiovascular morbidity and cause-specific mortality in MINOCA.METHODS: This is a registry-based cohort study using data from patients admitted to Swedish coronary care units. We investigated various nonfatal outcomes (recurrent MI, hospitalization for heart failure or stroke) and fatal outcomes (cardiovascular, respiratory or cancer-related mortality) in 4069 patients without apparent acute cardiovascular disease, used as non-MI controls, 7266 patients with first-time MINOCA and 69 267 patients with first-time MI-CAD.RESULTS: Almost all event rates (median follow-up 3.8 years) increased in a stepwise fashion across the three cohorts [rates of major adverse events (MAE; composite of all-cause mortality, recurrent MI, hospitalization for heart failure or stroke): n = 268 (6.6%), n = 1563 (21.5%), n = 17 777 (25.7%), respectively]. Compared to non-MI controls, MINOCA patients had an adjusted hazard ratio (HR) of 2.12 (95% confidence interval 1.84-2.43) regarding MAE. MINOCA patients had a substantial risk of cardiovascular mortality and the highest numerical risks of respiratory and cancer-related mortality. Male sex, previous heart failure and chronic obstructive pulmonary disease had a stronger prognostic impact in MINOCA than in MI-CAD. Female MINOCA patients with atrial fibrillation were at particular risk.CONCLUSIONS: Patients with first-time MINOCA have a considerable risk of adverse events. This stresses the need for a comprehensive search of the cause of MINOCA, thorough treatment of underlying disease triggers and close follow-up.
|
|
| 14. |
- Eggers, Kai M., 1962-, et al.
(författare)
-
Predicting outcome in acute myocardial infarction : an analysis investigating 175 circulating biomarkers
- 2021
-
Ingår i: European Heart Journal. - : Oxford University Press. - 2048-8726 .- 2048-8734. ; 10:7, s. 806-812
-
Tidskriftsartikel (refereegranskat)abstract
- Aims There is a paucity of studies comprehensively comparing the prognostic value of larger arrays of biomarkers indicative of different pathobiological axes in acute myocardial infarction (MI).Methods and results In this explorative investigation, we simultaneously analysed 175 circulating biomarkers reflecting different inflammatory traits, coagulation activity, endothelial dysfunction, atherogenesis, myocardial dysfunction and damage, apoptosis, kidney function, glucose-, and lipid metabolism. Measurements were performed in samples from 1099 MI patients (SWEDEHEART registry) applying two newer multimarker panels [Proximity Extension Assay (Olink Bioscience), Multiple Reaction Monitoring mass spectrometry]. The prognostic value of biomarkers regarding all-cause mortality, recurrent MI, and heart failure hospitalizations (median follow-up <= 6.6years) was studied using Lasso analysis, a penalized logistic regression model that considers all biomarkers simultaneously while minimizing the risk for spurious findings. Tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2), ovarian cancer-related tumour marker CA 125 (CA-125), and fibroblast growth factor 23 (FGF-23) consistently predicted all-cause mortality in crude and age/sex-adjusted analyses. Growth-differentiation factor 15 (GDF-15) was strongly predictive in the crude model. TRAIL-R2 and B-type natriuretic peptide (BNP) consistently predicted heart failure hospitalizations. No biomarker predicted recurrent MI. The prognostic value of all biomarkers was abrogated following additional adjustment for clinical variables owing to our rigorous statistical approach.Conclusion Apart from biomarkers with established prognostic value (i.e. BNP and to some extent GDF-15), several 'novel' biomarkers (i.e. TRAIL-R2, CA-125, FGF-23) emerged as risk predictors in patients with MI. Our data warrant further investigation regarding the utility of these biomarkers for clinical decision-making in acute MI.
|
|
| 15. |
- Eggers, Kai M., 1962-, et al.
(författare)
-
Sex-differences in circulating biomarkers during acute myocardial infarction : An analysis from the SWEDEHEART registry
- 2021
-
Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 16:4 April
-
Tidskriftsartikel (refereegranskat)abstract
- Background Sex-differences in the pathobiology of myocardial infarction are well established but incompletely understood. Improved knowledge on this topic may help clinicians to improve management of men and women with myocardial infarction. Methods In this registry-based cohort study (SWEDEHEART), we analyzed 175 circulating biomarkers reflecting various pathobiological axes in 856 men and 243 women admitted to Swedish coronary care units because of myocardial infarction. Two multimarker panels were applied (Proximity Extension Assay [Olink Bioscience], Multiple Reaction Monitoring mass spectrometry). Lasso analysis (penalized logistic regression), multiple testing-corrected Mann- Whitney tests and Cox regressions were used to assess sex-differences in the concentrations of these biomarkers and their implications on all-cause mortality and major adverse events (median follow-up up to 6.6 years). Results Biomarkers provided a very high discrimination between both sexes, when considered simultaneously (c-statistics 0.972). Compared to women, men had higher concentrations of six biomarkers with the most pronounced differences seen for those reflecting atherogenesis, myocardial necrosis and metabolism. Women had higher concentrations of 14 biomarkers with the most pronounced differences seen for those reflecting activation of the reninangiotensin- aldosterone axis, inflammation and for adipokines. There were no major variations between sexes in the associations of these biomarkers with outcome. Conclusions Severable sex-differences exist in the expression of biomarkers in patients with myocardial infarction. While these differences had no impact on outcome, our data suggest the presence of various sex-related pathways involved in the development of coronary atherosclerosis, the progression to plaque rupture and acute myocardial damage, with a greater heterogeneity in women.
|
|
| 16. |
|
|
| 17. |
- Gard, Anton, et al.
(författare)
-
Diagnosing type 2 myocardial infarction in clinical routine. A validation study
- 2019
-
Ingår i: Scandinavian Cardiovascular Journal. - : TAYLOR & FRANCIS LTD. - 1401-7431 .- 1651-2006. ; 53:5, s. 259-265
-
Tidskriftsartikel (refereegranskat)abstract
- Objective. Since 2010, myocardial infarction (MI) patients reported to the Swedish registry for MI (SWEDEHEART) are routinely classified into MI subtypes. The registry has been used to study the type 2 MI population but the MI-classification in the registry has not previously been validated. The aim of this study was to validate the type 2 MI classification in the registry. Design. A total of 772 patients diagnosed with MI in 2011 and reported to the SWEDEHEART registry were included in the study. All patients were retrospectively classified into MI type 1-5 or myocardial injury by independent reviewers strictly adhering to The Third Universal Definition of MI. This gold standard classification was compared with the classification in the registry. Results. Forty-eight (6.2%) patients were classified as type 2 MI in the registry compared with 93 (12.0%) according to the gold standard classification. A type 2 MI diagnosis was confirmed in 30 out of the 48 type 2 MI patients in the registry (PPV: 62.5%). There was a moderate rate of agreement (kappa: 0.43) between the gold standard classification and the classification in SWEDEHEART in deciding a type 2 MI diagnosis. Conclusion. The SWEDEHEART registry agreed moderately with the gold standard in classifying patients with type 2 MI diagnosis. Thus, studies on patients with type 2 MI in the registry should be interpreted with caution. Since the prevalence of type 2 MI is substantially underestimated in SWEDEHEART, the registry should not be used to study the prevalence of type 2 MI.
|
|
| 18. |
- Gard, Anton, et al.
(författare)
-
Interphysician agreement on subclassification of myocardial infarction.
- 2018
-
Ingår i: Heart. - : BMJ. - 1355-6037 .- 1468-201X. ; 104:15, s. 1284-1291
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: The universal definition of myocardial infarction (MI) differentiates MI due to oxygen supply/demand mismatch (type 2) from MI due to plaque rupture (type 1) as well as from myocardial injuries of non-ischaemic or multifactorial nature. The purpose of this study was to investigate how often physicians agree in this classification and what factors lead to agreement or disagreement.METHODS: A total of 1328 patients diagnosed with MI at eight different Swedish hospitals 2011 were included. All patients were retrospectively reclassified into different MI or myocardial injury subtypes by two independent specially trained physicians, strictly adhering to the third universal definition of MI.RESULTS: Overall, there was a moderate interobserver agreement with a kappa coefficient (κ) of 0.55 in this classification. There was substantial agreement when distinguishing type 1 MI (κ: 0.61), compared with moderate agreement when distinguishing type 2 MI (κ: 0.54). In multivariate logistic regression analyses, ST elevation MI (P<0.001), performed coronary angiography (P<0.001) and larger changes in troponin levels (P=0.023) independently made the physicians agree significantly more often, while they disagreed more often with symptoms of dyspnoea (P<0.001), higher systolic blood pressure (P=0.001) and higher C reactive protein levels on admission (P=0.016).CONCLUSION: Distinguishing MI types is challenging also for trained adjudicators. Although strictly adhering to the third universal definition of MI, differentiation between type 1 MI, type 2 MI and myocardial injury only gave a moderate rate of interobserver agreement. More precise and clinically applicable criteria for the current classification, particularly for type 2 MI diagnosis, are urgently needed.
|
|
| 19. |
- Hjort, Filip, 1991, et al.
(författare)
-
Optical microprism cavities based on dislocation-free GaN
- 2020
-
Ingår i: Applied Physics Letters. - : AIP Publishing. - 0003-6951 .- 1077-3118. ; 117:23
-
Tidskriftsartikel (refereegranskat)abstract
- Three-dimensional growth of nanostructures can be used to reduce the threading dislocation density that degrades III-nitride laser performance. Here, nanowire-based hexagonal GaN microprisms with flat top and bottom c-facets are embedded between two dielectric distributed Bragg reflectors to create dislocation-free vertical optical cavities. The cavities are electron beam pumped, and the quality (Q) factor is deduced from the cavity-filtered yellow luminescence. The Q factor is similar to 500 for a 1000nm wide prism cavity and only similar to 60 for a 600nm wide cavity, showing the strong decrease in Q factor when diffraction losses become dominant. Measured Q factors are in good agreement with those obtained from quasi-3D finite element frequency-domain method and 3D beam propagation method simulations. Simulations further predict that a prism cavity with a 1000nm width will have a Q factor of around 2000 in the blue spectral regime, which would be the target regime for real devices. These results demonstrate the potential of GaN prisms as a scalable platform for realizing small footprint lasers with low threshold currents.
|
|
| 20. |
|
|
| 21. |
- Hjort, Marcus, 1988-, et al.
(författare)
-
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries : Results From the PLATO Trial
- 2023
-
Ingår i: Journal of the American Heart Association. - : American heart association. - 2047-9980. ; 12:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background: The pathobiology of myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) is often uncertain. Investigating biomarker concentrations and their changes may offer novel pathophysiological insights.Methods and Results: In this post hoc study of the PLATO (Platelet Inhibition and Patient Outcomes) trial, concentrations of hs‐cTnT (high‐sensitivity cardiac troponin T), NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), hs‐CRP (high‐sensitivity C‐reactive protein), and GDF‐15 (growth differentiation factor 15) were measured in patients with MINOCA at baseline (n=554) and at 1‐month follow‐up (n=107). For comparisons, biomarkers were also measured in patients with MI with obstructive (stenosis ≥50%) coronary artery disease (baseline: n=11 106; follow‐up: n=2755]). Adjusted linear regression models were used to compare concentrations and their short‐ and long‐term changes. The adjusted geometric mean ratios (GMRs) in patients with MINOCA (median age, 61 years; 50.4% women) indicated lower hs‐cTnT (GMR, 0.77 [95% CI, 0.68–0.88]) but higher hs‐CRP (GMR, 1.21 [95% CI, 1.08–1.37]) and GDF‐15 concentrations (GMR, 1.06 [95% CI, 1.02–1.11]) at baseline compared with patients with MI with obstructive coronary artery disease, whereas NT‐proBNP concentrations were similar. Temporal decreases in hs‐cTnT, NT‐proBNP, and hs‐CRP concentrations until 1‐month follow‐up were more pronounced in patients with MINOCA. At follow‐up, patients with MINOCA had lower concentrations of hs‐cTnT (GMR, 0.71 [95% CI, 0.60–0.84]), NT‐proBNP (GMR, 0.45 [95% CI, 0.36–0.56]), and hs‐CRP (GMR, 0.68 [95% CI, 0.53–0.86]). One‐month GDF‐15 concentrations were similar between both groups with MI.Conclusions: Biomarker concentrations suggest greater initial inflammatory activity, similar degree of myocardial dysfunction, and less pronounced myocardial injury during the acute phase of MINOCA compared with MI with obstructive coronary artery disease but also faster myocardial recovery.CLINICAL TRAIL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00391872.
|
|
| 22. |
- Hjort, Marcus, et al.
(författare)
-
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
- 2021
-
Ingår i: Clinical Biochemistry. - : Elsevier BV. - 0009-9120 .- 1873-2933. ; 42, s. 1268-1268
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Differences in biomarkers reflective of pathobiology and prognosis between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are incompletely understood and may offer insights for tailoring of treatment. Methods: This registry-based study included 538 STEMI and 544 NSTEMI patients admitted 2008–2014. Blood samples were collected day 1–3 after admission and 175 biomarkers were analyzed using Proximity Extension Assay and Multiple Reaction Monitoring mass spectrometry. Adjusted Lasso analysis (penalized logistic regression model) was used to select biomarkers that discriminated STEMI from NSTEMI patients. Biomarkers identified by the Lasso analysis were then evaluated in adjusted Cox regressions for associations with death or major adverse cardiovascular events. Results: Biomarkers strongly discriminated STEMI and NSTEMI when considered simultaneously in adjusted Lasso analysis (c-statistic 0.764). Eleven biomarkers independently discriminated STEMI and NSTEMI; seven showing higher concentrations in STEMI: myoglobin, N-terminal pro-B-type natriuretic peptide, serum amyloid A-1 and A-2 protein, ST2 protein, interleukin-6 and chitinase-3-like protein 1; and four showing higher concentrations in NSTEMI: fibroblast growth factor 23, membrane-bound aminopeptidase P, tumor necrosis factor-related activation-induced cytokine and apolipoprotein C-I. During up to 6.6 years of prognostic follow-up, none of these biomarkers exhibited different associations with adverse outcome between STEMI and NSTEMI. Conclusions: In the acute setting, biomarkers indicated greater myocardial dysfunction and inflammation in STEMI, whereas they displayed a more diverse pathophysiologic pattern in NSTEMI patients. These biomarkers were similarly prognostic in STEMI and NSTEMI patients. The results do not support treating STEMI and NSTEMI patients differently based on the concentrations of these biomarkers.
|
|
| 23. |
- Hjort, Marcus, 1988-
(författare)
-
Identification of pathophysiological and prognostic biomarkers in different types of myocardial infarction
- 2022
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The pathophysiological mechanisms of myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) are largely unknown. Analogous, differences in pathobiology between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are incompletely understood. The overall aim of this thesis was to explore whether concentrations of cardiovascular biomarkers during the acute and stable phase may offer novel pathophysiological insights, comparing MINOCA (coronary stenoses <50%) to myocardial infarction with obstructive coronary arteries (MI-CAD; stenoses ≥50%) and controls, or STEMI to NSTEMI. Also, the prognostic implications of biomarkers were explored.The study populations consisted of subjects included in the quality registry SWEDEHEART at hospitalization in two cohorts (n=18,943 and n=1082), in the SMINC study at three-month follow-up (n=292), and finally in the PLATO trial during hospitalization (n=11,660) and at one-month follow-up (n=2862). Cardiovascular biomarkers were analyzed with proximity extension assay (91 biomarkers), multiple reaction monitoring assay (84 biomarkers) and standard laboratory chemistry. Lasso analysis (penalized logistic regression model) and multiple linear regression were used to select biomarkers that discriminated MINOCA from MI-CAD patients or controls, and the former was also used to compare STEMI to NSTEMI patients. Adjusted Cox regression was mainly used for prognostic evaluations.The combined pattern of several inflammatory biomarkers suggested that MINOCA had a more pronounced chronic inflammatory activity compared to MI-CAD and controls. High sensitivity C-reactive protein (hs-CRP) concentrations were also initially higher in MINOCA than MI-CAD during the hospital stay, although later temporal changes of hs-CRP indicated less acute phase reaction in MINOCA. As reflected by high sensitivity cardiac troponin T (hs-cTnT) and natriuretic peptides, there was a lower degree of myocardial injury in MINOCA than MI-CAD during hospital stay, but also a faster recovery in MINOCA and less persistent myocardial damage and dysfunction. Compared to controls however, there was a higher degree of residual myocardial dysfunction in MINOCA three months later. Corresponding with this, higher in-hospital hs-cTnT concentrations in MINOCA independently predicted poor one-year outcomes, in particular cardiovascular mortality and heart failure. Finally, samples three months post-MINOCA displayed lower concentrations of tissue-type plasminogen activator than post-MI-CAD patients, suggesting less persistent coagulation activation.In STEMI and NSTEMI patients, biomarkers indicated greater myocardial damage and dysfunction in the acute phase in STEMI, together with more pronounced inflammatory activity. They also displayed a more diverse pathophysiological pattern in NSTEMI. All of the biomarkers that separated STEMI from NSTEMI were however similarly prognostic for mortality and adverse events between the two MI groups.In conclusion, extensive biomarker investigations combined with advanced statistical analyses displayed intriguing aspects of pathobiology in MINOCA and differences between STEMI and NSTEMI. Some of these biomarkers were also related to clinical outcome.
|
|
| 24. |
- Hjort, Marcus, et al.
(författare)
-
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
- 2019
-
Ingår i: Clinical Chemistry. - : AMER ASSOC CLINICAL CHEMISTRY. - 0009-9147 .- 1530-8561. ; 65:8, s. 1023-1030
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Around 5%-10% of patients with myocardial infarction (MI) present with nonobstructive coronary arteries (MINOCA). We aimed to assess pathophysiological mechanisms in MINOCA by extensively evaluating cardiovascular biomarkers in the stable phase after an event, comparing MINOCA patients with cardiovascular healthy controls and MI patients with obstructive coronary artery disease (MI-CAD).METHODS: Ninety-one biomarkers were measured with a proximity extension assay 3 months after MI in 97 MINOCA patients, 97 age-and sex-matched MI-CAD patients, and 98 controls. Lasso analyses (penalized logistic regression models) and adjusted multiple linear regression models were used for statistical analyses.RESULTS: In the Lasso analysis (MINOCA vs MI-CAD), 8 biomarkers provided discriminatory value: P-selectin glycoprotein ligand 1, C-X-C motif chemokine 1, TNF-related activation-induced cytokine, and pappalysin-1 (PAPPA) with increasing probabilities of MINOCA, and tissue-type plasminogen activator, B-type natriuretic peptide, myeloperoxidase, and interleukin-1 receptor antagonist protein with increasing probabilities of MI-CAD. Comparing MINOCA vs controls, 7 biomarkers provided discriminatory value: N-terminal pro-B-type natriuretic peptide, renin, NF-kappa-B essential modulator, PAPPA, interleukin-6, and soluble urokinase plasminogen activator surface receptor with increasing probabilities of MINOCA, and agouti-related protein with increasing probabilities of controls. Adjusted multiple linear regression analyses showed that group affiliation was associated with the concentrations of 7 of the 8 biomarkers in the comparison MINOCA vs MI-CAD and 5 of the 7 biomarkers in MINOCA vs controls.CONCLUSIONS: Three months after the MI, the biomarker concentrations indicated greater inflammatory activity in MINOCA patients than in both MI-CAD patients and healthy controls, and a varying degree of myocardial dysfunction among the 3 cohorts.
|
|
| 25. |
- Hjort, Marcus, et al.
(författare)
-
Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries
- 2018
-
Ingår i: American Heart Journal. - : Elsevier. - 0002-8703 .- 1097-6744. ; 200, s. 60-66
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is a recently recognized condition where biomarkers and prognosis are less well studied than in MI with obstructive coronary artery disease (MI-CAD). We therefore aimed to investigate the one-year prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels in MINOCA in comparison to MI-CAD.Methods: In this registry-based cohort study, we used data frompatientswith a discharge diagnosis ofMI, admitted between 2009 and 2013 to Swedish hospitals using the hs-cTnT assay. Only patients without previously known coronary artery disease were considered. Patients with and without coronary stenosis N50% were regarded to haveMI-CAD andMINOCA, respectively. Assessed outcomes included all-cause mortality, cardiovascular (CV) mortality and major CV events (MACE), defined as the composite of CV death or admissions for nonfatal MI, heart failure (HF) or ischemic stroke.Results: The study cohort consisted of 1639 MINOCA and 17,304 MI-CAD patients. In adjusted analyses, hs-cTnT (ln) in MINOCA patients predicted all-cause mortality (HR 1.32 [95% CI 1.11-1.56]), CVmortality (HR 2.11 [95% CI 1.51-2.96]) and MACE (HR 1.44 [95% CI 1.20-1.72]). Hs-cTnT (ln) also predicted readmissions for HF (HR 1.51 [95% CI 1.51-2.96]) but not non-fatal MI or stroke. Interaction analyses suggested that hs-cTnT (ln) was at least as prognostic in patients with MINOCA compared to MI-CAD.Conclusions: Hs-cTnT levels inMINOCA patients are strong and independent predictors of adverse outcome. Consideration of hs-cTnT levels is important for risk assessment of MINOCA patients.
|
|
| 26. |
|
|
| 27. |
- Knutagård, Marcus, et al.
(författare)
-
Ekonomiskt bistånd och hemlöshet
- 2019
-
Ingår i: Det yttersta skyddsnätet : Om arbete med socialbidrag - Om arbete med socialbidrag. - 9789144116341 ; , s. 223-245
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 28. |
- Larsson, Bengt, 1943-, et al.
(författare)
-
Logistik vid husbyggande : Några praktikfall
- 2008
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- Bakgrund: I slutet av 70-talet påbörjades studier om överförbrukning av material i byggproduktionen med FoU-Väst som pådrivare och SBUF som finansiär. Det genomfördes då ett antal “materialspills- projekt” som blev ganska uppmärksammade och som påverkade synen på hur viktigt det är att hantera byggmaterial på rätt sätt. Under de mer än trettio år som gått sedan dess har ett flertal utvecklingsprojekt om byggandets logistik genomförts. Men ämnet är inte uttömt, byggande innebär ständig utveckling och eftersom 50 % av kostnaderna i ett byggprojekt är kostnader för material finns det fortfarande många möjligheter till effektivisering. I detta utvecklingsprojekt har några arbetsplatser studerats samtidigt som samverkan med några byggmaterialleverantörer har undersökts.Syfte: Det finns ett betydande slöseriet inom byggmaterialhanteringen. Brister i inköps- och materialhanteringsprocessen påverkar i hög grad byggandets effektivitet. Exempel på detta är överproduktion, korrigeringsarbete, onödig förflyttning av material, stora materiallager, väntetid i produktionen och onödiga arbetskraftsförflyttningar. Allt detta rör logistiken på byggarbetsplatsen. Bygglogistik omfattar planering, organisering, koordinering och kontroll av materialflöden från råmaterial tills det att materialet byggts in i den färdiga byggnaden. Syftet med detta projekt har varit att identifiera och förklara faktorer som har betydelse för materialflödeskostnadernas struktur och storlek, och som är möjliga att påverka. Normala byggmaterial har valts ut för praktikfallsstudier – material som är besvärliga ur logistikperspektiv och som har en stor besparingspotential.Genomförande: Med stöd från SBUF har arbetet utförts av deltagare från PEAB och Högskolan i Halmstad. För att samla in materialet till rapporten gjordes en omfattande litteraturstudie. Vidare gjordes uppföljningar på sju olika husbyggnadsarbetsplatser och intervjuer med sex byggmaterialtillverkare/leverantörer genomfördes.Resultat: Erfarenheter från tidigare projekt: Det finns alltså en mängd studier gjorda som visar på olika brister i byggandets materialhantering och många menar att med utnyttjande av studiernas rekommendationer borde kostnaderna för material och hantering av material kunna minskas med bortåt 50 %. Den största vinsten kan nås genom att effektivisera hantering och lagring av byggmaterial. Reduktion av materialspill och minskade störningar kan också ge minskade logistikkostnader. Lägsta pris är ofta inte det samma som lägsta totalkostnad. Det fysiska flödet på byggarbetsplatsen kan förbättras genom att försöka skapa tillgång till nödvändigt byggmaterial utan att bygga upp för stora lager. Byggmaterial som lagras länge riskerar att användas till annat, fördärvas eller att stjälas. Byggmaterialterminaler kan i vissa fall vara ett alternativ till lager på byggarbetsplatsen. Många pekar på vikten av långsiktigt samarbete mellan leverantör och entreprenör/projekt. Men denna samverkan försvåras genom att byggarna går från projekt till projekt och att det krävs så många olika byggmaterial. Det kontinuerliga samarbetet och standardisering av kommunikation och produkter blir lidande på grund av detta.Under senare år har det blivit vanligare med import av byggmaterial. Import kan ge billigare priser men risken är att dessa vinster äts upp av ökande logistikkostnader.
|
|
| 29. |
- Lehto, Marcus, et al.
(författare)
-
A polymeric paraffin microactuator
- 2008
-
Ingår i: Journal of microelectromechanical systems. - 1057-7157 .- 1941-0158. ; 17:5, s. 1172-1177
-
Tidskriftsartikel (refereegranskat)abstract
- Paraffin wax is a promising material in microactuators not only because of its ability of producing large displacements and high forces at the same time but also because of the variety of manufacturing techniques available. In this paper, a simple actuator based on paraffin wax as the active material is fabricated and tested. Ultraviolet-curable epoxy is used in a technique combining simultaneous moulding and liquid-phase photopolymerization in a single-process step to build the stiff part of the actuator body. A heater is integrated in the paraffin reservoir, and a polyimide tape is used as the deflecting membrane. Thermornechanical analysis of the paraffin wax shows that it exhibits a volume expansion of 10%, including phase transitions and linear expansion. As for the actuator, a stroke of 90 mu m is obtained for the unloaded device, whereas 37 mu m is recorded with a 0.5-N contact load at a driving voltage of 0.71 V and a frequency of 1/32 Hz. The actuator can be used in microsystems, where both large strokes and forces are needed. The low-cost materials and low driving voltage also makes it suitable for disposable systems.
|
|
| 30. |
- Lehto, Marcus, 1973-
(författare)
-
Paraffin Actuators in Microfluidic Systems
- 2007
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- There is a need for reliable valves and pumps in microfluidics. A good microactuator is the key for low cost and high performance of these components.Paraffin wax is a promising material to be used as actuator material as is can produce large forces and large strokes. Further, the material is inexpensive and, none the less, the thermal heating of the material can be made with low voltages. All these properties are of interest in flow control components in microfluidics, and especially for disposables and in potable systems.In this work, paraffin wax has been used in devices and concepts. A valve for high-pressures, a peristaltic pump, a multi-stable actuator, and injector has been shown. A material study was performed on binary mixtures of pure paraffin (n-alkanes), and a concept for loading fluid into a sealed reservoir was shown as well. Several injectors were demonstrated in a Lab-on-a-chip system with other microfluidic components.High pressure applications in microfluidics along with the multi-stable actuator show good potential. However, the drive and control has to be further developed.
|
|
| 31. |
|
|
| 32. |
|
|
| 33. |
- Lehto, Marcus, et al.
(författare)
-
Rapid prototyping of a polymeric paraffin microactuator
- 2008
-
Ingår i: Journal of microelectromechanical systems. - 1057-7157 .- 1941-0158. ; 17:5, s. 1172-1177
-
Tidskriftsartikel (refereegranskat)abstract
- Paraffin wax is a promising material in microactuators not only because of its ability of producing large displacements and high forces at the same time but also because of the variety of manufacturing techniques available. In this paper, a simple actuator based on paraffin wax as the active material is fabricated and tested. Ultraviolet-curable epoxy is used in a technique combining simultaneous moulding and liquid-phase photopolymerization in a single-process step to build the stiff part of the actuator body. A heater is integrated in the paraffin reservoir, and a polyimide tape is used as the deflecting membrane. Thermomechanical analysis of the paraffin wax shows that it exhibits a volume expansion of 10%, including phase transitions and linear expansion. As for the actuator, a stroke of 90 mum is obtained for the unloaded device, whereas 37 mum is recorded with a 0.5-N contact load at a driving voltage of 0.71 V and a frequency of 1/32 Hz. The actuator can be used in microsystems, where both large strokes and forces are needed. The low-cost materials and low driving voltage also makes it suitable for disposable systems.
|
|
| 34. |
|
|
| 35. |
- Mörtberg, Josefin, et al.
(författare)
-
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
- 2023
-
Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 373, s. 64-71
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Patients with kidney failure have a high risk for cardiovascular events. We aimed to evaluate the prognostic importance of selected biomarkers related to haemostasis, endothelial function, and vascular regulation in patients with acute coronary syndrome (ACS), and to study whether this association differed in patients with renal dysfunction.METHODS: Plasma was collected in 1370 ACS patients included between 2008 and 2015. Biomarkers were analysed using a Proximity Extension Assay and a Multiple Reaction Monitoring mass spectrometry assay. To reduce multiplicity, biomarkers correlating with eGFR were selected a priori among 36 plasma biomarkers reflecting endothelial and vascular function, and haemostasis. Adjusted Cox regression were used to study their association with the composite outcome of myocardial infarction, ischemic stroke, heart failure or death. Interaction with eGFR strata above or below 60 ml/min/1.73 m 2 was tested. RESULTS: Tissue factor, proteinase-activated receptor, soluble urokinase plasminogen activator surface receptor (suPAR), thrombomodulin, adrenomedullin, renin, and angiotensinogen correlated inversely with eGFR and were selected for the Cox regression. Mean follow-up was 5.2 years during which 428 events occurred. Adrenomedullin, suPAR, and renin were independently associated with the composite outcome. Adrenomedullin showed interaction with eGFR strata (p = 0.010) and was associated with increased risk (HR 1.88; CI 1.44-2.45) only in patients with eGFR ≥60 ml/min/ 1.73 m 2. CONCLUSIONS: Adrenomedullin, suPAR, and renin were associated with the composite outcome in all. Adrenomedullin, involved in endothelial protection, showed a significant interaction with renal function and outcome, and was associated with the composite outcome only in patients with preserved kidney function.
|
|
| 36. |
- Singh, Kailash, et al.
(författare)
-
Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
- 2015
-
Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 5, s. 7767-
-
Tidskriftsartikel (refereegranskat)abstract
- Regulatory T (Treg) cells are characterized by the expression of CD4, CD25 and the intracellular Foxp3. However, these markers do not indicate whether Treg cells are thymic derived Treg (tTreg) cells or peripherally induced Treg (pTreg) cells. Recently, Helios and Neuropilin-1 (Nrp1) has been reported as potential markers for tTreg cells. Herein, we used flow cytometry to examine the proportion of CD4(+)CD8(-)CD25(+) Treg cells expressing Helios, Nrp1 and Foxp3 in thymus, pancreatic draining lymph nodes (PDLNs) and spleen of CD-1 mice, and thymus of NOD and C57BL/6 mice. The frequency of Helios(+) cells was higher than that of Nrp1(+) cells in CD4(+)CD8(-)CD25(+) and CD4(+)CD8(-)CD25(+)Foxp3(+) Treg cells in thymus. Interestingly, the proportion of IL-10(+), Ebi3(+) and CTLA-4(+) cells was higher in Helios(+) than Nrp1(+) tTreg cells. The anti-apoptotic activity of Helios(+) tTreg cells was higher in thymus compared to Nrp1(+) tTreg cells. Nrp1 seems to be expressed at a later developmental stage compared to Helios and Foxp3. Furthermore, the expression of Nrp1 in CD4(+)CD25(+) T cells of younger mice did not increase after stimulating them in vitro with anti-CD3 and -CD28. Thus, under these conditions, Helios could be considered a more reliable marker for distinguishing tTreg cells from pTreg cells than Nrp1.
|
|
| 37. |
- Warme, Jonatan, et al.
(författare)
-
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
- 2023
-
Ingår i: International Journal of Molecular Sciences. - : MDPI AG. - 1661-6596 .- 1422-0067. ; 44
-
Tidskriftsartikel (refereegranskat)abstract
- Myocardial infarction (MI) with obstructive coronary artery disease (MI-CAD) and MI in the absence of obstructive coronary artery disease (MINOCA) affect different populations and may have separate pathophysiological mechanisms, with greater inflammatory activity in MINOCA compared to MI-CAD. Helicobacter pylori (Hp) can cause systemic inflammation and has been associated with cardiovascular disease (CVD). We aimed to investigate whether Hp infection is associated with concentrations of protein biomarkers of inflammation and CVD. In a case-control study, patients with MINOCA (n = 99) in Sweden were included, complemented by matched subjects with MI-CAD (n = 99) and controls (n = 100). Protein biomarkers were measured with a proximity extension assay in plasma samples collected 3 months after MI. The seroprevalence of Hp and cytotoxin-associated gene A (CagA) was determined using ELISA. The associations between protein levels and Hp status were studied with linear regression. The prevalence of Hp was 20.2%, 19.2%, and 16.0% for MINOCA, MI-CAD, and controls, respectively (p = 0.73). Seven proteins were associated with Hp in an adjusted model: tissue plasminogen activator (tPA), interleukin-6 (IL-6), myeloperoxidase (MPO), TNF-related activation-induced cytokine (TRANCE), pappalysin-1 (PAPPA), soluble urokinase plasminogen activator receptor (suPAR), and P-selectin glycoprotein ligand 1 (PSGL-1). Hp infection was present in one in five patients with MI, irrespective of the presence of obstructive CAD. Inflammatory proteins were elevated in Hp-positive subjects, thus not ruling out that Hp may promote an inflammatory response and potentially contribute to the development of CVD.
|
|
| 38. |
|
|
| 39. |
|
|
